Category: Rheumatology/Arthritis
Global Rheumatology/Arthritis
-
The 2025-2030 World Outlook for Musculoskeletal Diseases
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
2024 Global Forecast for Low-Code Development Platform Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Computer Systems Design Services industry. The product or service category is within the NAICS Computer Systems Design Services industry. The global market is expected to ... Read More
-
Rheumatology Therapeutics Market by Indication (Ankylosing Spondylitis, Gout, Osteoarthritis), Distribution Channel (Offline Mode, Online Stores) - Global Forecast 2024-2030
... reach USD 33.24 billion in 2024, at a CAGR 6.51% to reach USD 48.58 billion by 2030. Global Rheumatology Therapeutics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Rheumatology Therapeutics ... Read More
-
Generic Musculoskeletal Disorders Drugs Global Market Report 2024
... By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Drug Store; Online PharmacyCovering: Pfizer Inc.; Sanofi S.A.; Eli Lilly and Company; Ampio Pharmaceuticals Inc.; Amgen Inc. Generic Musculoskeletal Disorders Drugs Global Market Report 2024 from The Business ... Read More
-
Tofacitinib Global Market Opportunities And Strategies To 2032 Including: 1) By Drug Class: Antirheumatic; Janus kinase inhibitor; Immunosuppressant 2) By Dosage Strength: 5mg; 10mg; 11mg; 22mg 3) By Indication: Ulcerative Colitis; Rheumatoid Arthritis; Psoriasis 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy Covering: Pfizer Inc.; Beacon Pharmaceuticals PLC; Pharmascience Inc.; Qilu Pharmaceutical Co., Ltd; Delta Pharma Limited
... Pharmacy; Retail Pharmacy; Online PharmacyCovering: Pfizer Inc.; Beacon Pharmaceuticals PLC; Pharmascience Inc.; Qilu Pharmaceutical Co., Ltd; Delta Pharma Limited Tofacitinib Global Market Opportunities And Strategies To 2032 from The Business Research Company provides the strategists; ... Read More
-
Autoimmune Disease Diagnostics: Global Markets
... and region. Report Includes: 41 data tables and 30 additional tables An overview of the global market landscape related to the autoimmune disease diagnostics In-depth analysis of global market trends, featuring historical revenue data for ... Read More
-
Global Rheumatoid Arthritis Drugs Market 2024-2028
... rheumatoid arthritis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Remicade Biosimilar Global Market Report 2023 Including: 1) By Type: 100mg/10ml; 500mg/50ml 2) By Disease Indication: Ulcerative Colitis; Rheumatoid Arthritis; Ankylosing Spondylitis; Crohn’s Disease; Psoriatic Arthritis; Plaque Psoriasis 3) By Application: Blood Disorders; Oncology Diseases Covering: AbbVie Inc.; Novartis AG; Amgen Inc; Viatris Inc.; Teva Pharmaceutical Industries Ltd.
... Novartis AG; Amgen Inc; Viatris Inc.; Teva Pharmaceutical Industries Ltd. Remicade Biosimilar Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess ... Read More
-
Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) - Global Forecast to 2028
... size is projected to reach USD 40.4 billion by 2028 from USD 29.0 billion in 2023, at a CAGR of 6.9% during the forecast period. Expanding the number of plasma collection centers allows market players ... Read More
-
Rheumatoid Arthritis Drugs Market, Size, Share, Global Forecast 2023-2030, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis
... Research. Rheumatoid Arthritis (RA) is an autoimmune condition characterized by inflammation and joint pain. It occurs when the immune system malfunctions and targets the synovium, the lining of the joints. Generally, RA affects symmetrical joints ... Read More
-
Rheumatoid Arthritis Drugs Market by Drug Class (Disease-modifying Anti-rheumatic Drugs, Nonsteroidal Anti-inflammatory Drugs, Corticosteroids, Uric Acid Drugs, and Others), Route of Administration (Oral and Parenteral), and Sales Channel (Prescription-based Drugs, and Over-the-counter Drugs): Global Opportunity Analysis and Industry Forecast, 2027
... Analysis and Industry Forecast, 2027 The Rheumatoid Arthritis (RA) drugs market refers to the pharmaceuticals and biologic therapies developed for the treatment of rheumatoid arthritis, an autoimmune disease characterized by chronic inflammation of the joints. ... Read More
-
Global Autoinjectors Market (4th Edition), 2021-2035 Distribution by Type of Autoinjector (Disposable and Reusable), Route of Administration (Subcutaneous and Intramuscular), Type of Molecule (Monoclonal Antibody, Peptide, Protein, and Small Molecule), Therapeutic Indication (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Migraine, Diabetes, and Others) and Geography (North America, Europe, Asia-Pacific, and Rest of the World): Industry Trends and Global Forecasts
... Rheumatoid Arthritis, Migraine, Diabetes, and Others) and Geography (North America, Europe, Asia-Pacific, and Rest of the World): Industry Trends and Global Forecasts According to the National Health Interview Survey (NHIS), nearly 52% of the adult ... Read More
-
Fc Fusion Therapeutics Market, 2021-2030 Distribution by Target Indications (Neutropenia, Graft Versus Host Disease, Breast Cancer, Rheumatoid Arthritis, Non-Small Cell Lung Cancer, Neovascular (Wet) Age-related Macular Degeneration (AMD), Hemophilia A, Neuromyelitis Optica Spectrum Disorders and Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2021-2030
... Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): ... Read More
-
Autoinjectors Market (Type: Disposable and Reusable; Technology: Handheld and Wearable; Indication: Multiple Sclerosis, Rheumatoid Arthritis, Diabetes, Anaphylaxis, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
... Report TMR’s report on the global Autoinjectors Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from ... Read More
-
Autoinjectors Market by Usage (Reusable, Disposable), Technology (Manual, Automatic), Therapy (Rheumatoid Arthritis, Diabetes, Anaphylaxis), Route of administration (SC, IM), Volume (<3ml, >3ml), End User (Home Care, Hospitals) - Global Forecast to 2028
... devices market is projected to reach USD 1.7 billion in 2028 from USD 0.9 billion in 2023, growing at a CAGR of 14.0%. Where as, the autoinjector finished formulations market is projected to reach USD ... Read More
-
Adrenocorticotropic Hormone Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Source (Natural, Synthetic): By Indication (Rheumatology, Neurology, Nephrotic Syndrome, Ophthalmology); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
... By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) Global Adrenocorticotropic Hormone Market Size Set to Cross USD 2.1 Billion by 2029 Global adrenocorticotropic hormone market is flourishing because of increasing ... Read More
-
Global Immunology Market Size study & Forecast, by Drug Class (Monoclonal Antibody, Immunosuppressants, Fusion Proteins, Others) by Disease Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Analysis, 2022-2029
... Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Analysis, 2022-2029 Global Immunology Market is valued at approximately USD 97.93 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.5% ... Read More
-
Global HUMIRA (Adalimumab) Drug Market Report and Forecast 2023-2031
... the increasing prevalence of autoimmune diseases and the growing adoption of biologic drugs for their treatment. The market is projected to grow at a CAGR of 1% during the forecast period. HUMIRA (Adalimumab) Drug Market: ... Read More
-
Global Foot and Ankle Devices Market Size, Share & Industry Trends Analysis Report By Application (Trauma, Osteoarthritis, Rheumatoid Arthritis, Hammertoe, Osteoporosis, Neurological Disorders and Bunions), By Product, By Regional Outlook and Forecast, 2022 - 2028
... The Global Foot And Ankle Devices Market size is expected to reach $6.1 billion by 2028, rising at a market growth of 7.1% CAGR during the forecast period. Many foot and ankle fractures brought on ... Read More
-
Autoinjectors Market - By Type (Disposable, Reusable), By Route of Administration (Subcutaneous, Intramuscular), By Therapy, (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Diabetes, Oncology, Asthma, Migraine, Hormone Therapy), By End-use (Hospital & Clinics, Homecare Settings) & Global Forecast, 2023 - 2032
... Forecast, 2023 - 2032 Global Autoinjectors Market is slated to grow exponentially by 2032, owing to the rising demand for targeted therapies, in light of the growing prevalence of chronic diseases. In addition, introduction to ... Read More
-
Musculoskeletal Disorders Drugs Global Market Briefing 2023
... consumption, the market was $13.4 and in terms of global GDP, the market was 0.09%. Musculoskeletal disorders drugs was the sixth largest segment within the market accounting for 6.5% preceded and followed by cardiovascular drugs ... Read More
-
Global Adalimumab Market - 2022-2029
... forecast period (2022-2029). Adalimumab is approved under the brand name Humira for the treatment of Rheumatoid Arthritis (RA), Juvenile Idiopathic Arthritis (JIA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS), Crohn's Disease (CD), and Plaque Psoriasis (Ps). ... Read More
-
Rheumatoid Arthritis Drugs Market Size, Share & Trends Report, 2022-2030
... can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. The global Rheumatoid Arthritis Drugs market size will reach USD million ... Read More
-
Global Prefilled Syringes Market Size, Share & Industry Trends Analysis Report By Application (Diabetes, Anaphylaxis, Rheumatoid Arthritis), By Therapeutics, By Material (Glass-based and Plastic-based), By Design, By Regional Outlook and Forecast, 2022 – 2028
... Global Prefilled Syringes Market size is expected to reach $11.9 billion by 2028, rising at a market growth of 10.5% CAGR during the forecast period. A single-dose packet of vaccination attached with a needle on ... Read More
-
Musculoskeletal Disorders Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... of per capita consumption, the market was $12.7 and in terms of global GDP, the market was 0.11%. Musculoskeletal disorders drugs was the sixth largest segment within the market accounting for 6.7% preceded and followed ... Read More
Research Assistance
